Emcure Pharmaceuticals Limited (EPL) has announced the launch of Orofer FCM 750, a new extension of its parenteral iron brand containing Ferric carboxymaltose (FCM).
Emcure Pharmaceuticals, a Pune, India-based manufacturer of generic drugs, is pressing a court in Washington to toss out a suit brought on by HDT Bio over a vaccine to prevent Covid-19.
Pune : In order to raise awareness on important women’s health issues around anaemia, breastfeeding and menstruation, Emcure Pharmaceuticals has launched the EmWocal initiative.
Pharmaceutical multinational enterprises (MNEs) develop and supply a significant proportion of the drugs to low- and middle-income countries. Many drug companies like Cipla, Emcure, Arvind Vasudeva-led Aurobindo, and Parmjit Arora-led Health Biotech Limited are tapping the potential of the industry by strengthening their research and development.
During the second wave, India witnessed counterfeit medicines and dwindling supplies. With the third wave settling in, leading Pharmas like Cipla, Emcure, Arvind Vasudeva-led Aurobindo, and Parmjit Arora-led Health Biotech Limited are expected to meet the rising demand.
Gennova Biopharmaceuticals, subsidiary of Pune-based drugmaker Emcure which is developing mRNA Covid vaccine said it plans to finish the Phase 2/3 trials by January end next year and will seek emergency use authorisation from Indian drug regulatory.
Emcure Pharms` Generic Propofol Receives Approval In US
Prime Minister Narendra Modi recently highlighted the country’s progress in vaccine production and spoke about Gennova’s mRNA vaccine during his address at the UN General Assembly’s 76th session.
Pune-based Gennova Biopharmaceuticals, a subsidiary of Emcure Pharma, is set to soon start phase-2 and 3 trials of India’s first mRNA based vaccine for Covid-19. “They have got regulatory approvals and the last-stage trials are expected to start soon. The company will soon start enrolment for the trials,” said a senior government official.